12/03/2025
At Salmonics, our mission is simple: to create high-performance, sustainable proteins that researchers can trust. And the data backs it up.
The landmark study by Laidmäe et al. (2006) confirmed that salmon-derived coagulation proteins are not only safe, but scientifically exceptional:
🧬 Retained full clotting function and mechanical stability after sterilization and lyophilization
🧫 Achieved >99.999% reduction in viral load, ensuring purity and biosafety
🐀 Showed no adverse immune or coagulation reactions in animal models
💵 Demonstrated potential for low-cost, large-scale production using farmed-salmon plasma
These findings form the foundation of Salmonics’ product line, including our:
🔹 Salmon Fibrinogen — high-purity, mammal-free source for wound-healing and scaffold development
🔹 Salmon Thrombin — stable, efficient catalyst for tissue-engineering and biomedical research
🔹 Salmon Fibrin — sustainable scaffold base for regenerative-medicine applications
Each product is derived from North Atlantic salmon byproducts, minimizing aquaculture waste while maximizing research performance and biosafety.
From the ocean to the operating table, Salmonics is helping scientists and manufacturers move toward a cleaner, more sustainable future in biomedicine.
📄 Reference: Laidmäe I. et al. (2006) Biomaterials 27(34): 5771–5779 https://hubs.la/Q03TQ93F0
🌐 Learn more about our salmon-derived proteins at https://hubs.la/Q03TQ9wK0
